{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:05:14Z","timestamp":1777593914897,"version":"3.51.4"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171470","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T14:07:16Z","timestamp":1486390036000},"page":"e0171470","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Imputation of adverse drug reactions: Causality assessment in hospitals"],"prefix":"10.1371","volume":"12","author":[{"given":"Fabiana Rossi","family":"Varallo","sequence":"first","affiliation":[]},{"given":"Cleopatra S.","family":"Planeta","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-4049","authenticated-orcid":true,"given":"Maria Teresa","family":"Herdeiro","sequence":"additional","affiliation":[]},{"given":"Patricia de Carvalho","family":"Mastroianni","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"ref1","unstructured":"WHO-UMC. The use of the WHO-UMC system for standardised case causality assessment. 2010. [Last accessed on 2015 nov 16]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/who-umc.org\/Graphics\/24734.pdf\" xlink:type=\"simple\">http:\/\/who-umc.org\/Graphics\/24734.pdf<\/ext-link>"},{"issue":"6","key":"ref2","first-page":"374","article-title":"Causal or casual? The role of causality assessment in pharmacovigilance","volume":"17","author":"RH Meyboom","year":"1997","journal-title":"Drug Safety"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jclinepi.2012.04.015","article-title":"An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance","volume":"65","author":"H The\u00f3phile","year":"2012","journal-title":"Journal of Clinical Epidemiology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40264-012-0002-x","article-title":"A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases","volume":"36","author":"PM Coloma","year":"2013","journal-title":"Drug Safety"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.rmedc.2009.01.004","article-title":"Algorithms for assessing the probability of an Adverse Drug Reaction","volume":"2","author":"MJ Doherty","year":"2009","journal-title":"Respiratory Medicine CME"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00002018-200831010-00003","article-title":"Methods for causality assessment of adverse drug reactions: a systematic review","volume":"31","author":"TB Agbabiaka","year":"2008","journal-title":"Drug Safety"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00002018-199921060-00001","article-title":"Pharmacovigilance in perspective","volume":"21","author":"RHB Meyboom","year":"1999","journal-title":"Drug Safety"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2710.2003.00475.x","article-title":"Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability","volume":"28","author":"AF Macedo","year":"2003","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"ref9","unstructured":"OPS. Buenas Pr\u00e1cticas de Farmacovigilancia para las Am\u00e9ricas. Washington, D. C.: OPS, \u00a9 2011. (Red PARF Documento T\u00e9cnico No. 5). 78 pages."},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00002018-200225060-00012","article-title":"Causal association in pharmacovigilance and pharmacoepidemiology thoughts on the application of the Austin Bradford-Hill criteria","volume":"25","author":"SAW Shakir","year":"2002","journal-title":"Drug Safety"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2298\/VSP140710104M","article-title":"Adverse drug reactions in hospitalized cardiac patients: characteristics and risk factors","volume":"72","author":"S Mugosa","year":"2015","journal-title":"Vojnosanit Pregl"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","article-title":"Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors","volume":"39","author":"MT Angamo","year":"2016","journal-title":"Drug Saf"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/pds.1138","article-title":"Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel","volume":"14","author":"AF Macedo","year":"2005","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"ref14","first-page":"353","article-title":"Adverse Drug Reactions in Clinical Practice: a Causality Assessment of a Case of Drug-Induced Pancreatitis","volume":"18","author":"A Farcas","year":"2009","journal-title":"The Journal of Gastrointestinal and Liver Diseases"},{"key":"ref15","unstructured":"WHO. International drug monitoring: the role of the national centers. WHO Technical Report Series n. 498. Genebra: WHO, 1972."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2125.1998.00667.x","article-title":"Frequency and cost of serious adverse drug reactions in a department of general medicine","volume":"45","author":"N Moore","year":"1998","journal-title":"B J Clin Pharmacol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"JR Landis","year":"1977","journal-title":"Biometrics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1345\/aph.1H088","article-title":"Adverse drug event reporting in the intensive care unit: a survey of current practices","volume":"40","author":"SL Kane-Gill","year":"2006","journal-title":"Annals of Pharmacotherapy"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03256843","article-title":"An investigation of disagreement in causality assessment of adverse drug reactions","volume":"25","author":"EC Davies","year":"2011","journal-title":"Pharmaceutical medicine"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/BF03261961","article-title":"Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRS","volume":"35","author":"SL Kane-Gill","year":"2012","journal-title":"Drug Safety"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0253-7613.125192","article-title":"A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions","volume":"46","author":"MN Belhekar","year":"2014","journal-title":"Indian J Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s40264-013-0083-1","article-title":"Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgments as reference","volume":"36","author":"H Th\u00e9ophile","year":"2013","journal-title":"Drug Safety"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00228-004-0869-2","article-title":"Agreement of expert judgment in causality assessment of adverse drug reactions","volume":"61","author":"Y Arimone","year":"2005","journal-title":"Eur J ClinPharmacol"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1365-2125.2012.04249.x","article-title":"An agenda for UK clinical pharmacology pharmacovigilance","volume":"73","author":"R Edwards","year":"2012","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40264-012-0014-6","article-title":"WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems","volume":"36","author":"SN Pal","year":"2013","journal-title":"Drug Safety"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jsps.2015.01.010","article-title":"Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions","volume":"24","author":"LM Khan","year":"2016","journal-title":"Saudi Pharm J"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1377\/hlthaff.2011.0190","article-title":"&apos;Global trigger tool&apos; shows that adverse events in hospitals may be ten times greater than previously measured","volume":"30","author":"DC Classen","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40264-015-0342-4","article-title":"Future proofing adverse event monitoring","volume":"38","author":"JD Seeger","year":"2015","journal-title":"Drug Safety"},{"key":"ref29","first-page":"48","article-title":"The importance of pharmacovigilance","year":"2002"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychores.2013.11.003","article-title":"Medications beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes","volume":"76","author":"ST De Vries","year":"2014","journal-title":"J Psychosom Rs"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0000000000000125","article-title":"Challenges in managing HIV in people who use drugs","volume":"28","author":"A Kamarulzaman","year":"2015","journal-title":"CurrOpin Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:52:28Z","timestamp":1540338748000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171470"}},"subtitle":[],"editor":[{"given":"Naoki","family":"Oiso","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171470","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]}}}